HKD 3.31
(-2.93%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 1.98 Billion HKD | -5.44% |
2022 | 2.08 Billion HKD | -2.48% |
2021 | 2.13 Billion HKD | 12.67% |
2020 | 1.89 Billion HKD | 22.13% |
2019 | 1.55 Billion HKD | 4.1% |
2018 | 1.48 Billion HKD | 55.62% |
2017 | 957.26 Million HKD | 64.43% |
2016 | 582.16 Million HKD | 9.5% |
2015 | 531.67 Million HKD | 19.63% |
2014 | 444.42 Million HKD | -36.13% |
2013 | 695.82 Million HKD | 4.96% |
2012 | 662.94 Million HKD | -26.38% |
2011 | 900.54 Million HKD | 35.09% |
2010 | 666.63 Million HKD | 15.22% |
2009 | 578.58 Million HKD | -5.29% |
2008 | 610.9 Million HKD | 33.55% |
2007 | 457.42 Million HKD | 31.91% |
2006 | 346.78 Million HKD | 15.99% |
2005 | 298.96 Million HKD | 0.39% |
2004 | 297.8 Million HKD | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q2 | 994.17 Million HKD | 0.0% |
2023 Q2 | 1.14 Billion HKD | 0.0% |
2023 Q4 | 856.74 Million HKD | 0.0% |
2023 FY | 1.96 Billion HKD | -5.44% |
2022 Q4 | 943.54 Million HKD | 0.0% |
2022 FY | 2.08 Billion HKD | -2.48% |
2022 Q2 | 1.13 Billion HKD | 0.0% |
2021 Q4 | 1.06 Billion HKD | 0.0% |
2021 Q2 | 1.1 Billion HKD | 0.0% |
2021 FY | 2.13 Billion HKD | 12.67% |
2020 Q4 | 1.08 Billion HKD | 0.0% |
2020 Q2 | 806.62 Million HKD | 0.0% |
2020 FY | 1.89 Billion HKD | 22.13% |
2019 FY | 1.55 Billion HKD | 4.1% |
2019 Q2 | 783.76 Million HKD | 0.0% |
2019 Q4 | 775.86 Million HKD | 0.0% |
2018 Q4 | 715.33 Million HKD | 0.0% |
2018 FY | 1.48 Billion HKD | 55.62% |
2018 Q2 | 774.34 Million HKD | 0.0% |
2017 Q2 | 352.95 Million HKD | 0.0% |
2017 FY | 957.26 Million HKD | 64.43% |
2017 Q4 | 604.3 Million HKD | 0.0% |
2016 Q4 | 316.88 Million HKD | 0.0% |
2016 Q2 | 265.28 Million HKD | 0.0% |
2016 FY | 582.16 Million HKD | 9.5% |
2015 FY | 531.67 Million HKD | 19.63% |
2015 Q4 | 353.24 Million HKD | 0.0% |
2015 Q2 | 178.42 Million HKD | 0.0% |
2014 Q2 | 175.98 Million HKD | 0.0% |
2014 Q4 | 268.44 Million HKD | 0.0% |
2014 FY | 444.42 Million HKD | -36.13% |
2013 Q3 | 173.95 Million HKD | -48.22% |
2013 FY | 695.82 Million HKD | 4.96% |
2013 Q4 | 111.99 Million HKD | -35.62% |
2013 Q2 | 335.98 Million HKD | 93.14% |
2013 Q1 | 173.95 Million HKD | 0.0% |
2012 Q4 | 173.95 Million HKD | 4.96% |
2012 Q1 | 165.73 Million HKD | 0.0% |
2012 FY | 662.94 Million HKD | -26.38% |
2012 Q2 | 165.73 Million HKD | 0.0% |
2012 Q3 | 165.73 Million HKD | 0.0% |
2011 Q3 | -1.89 Million HKD | 0.0% |
2011 Q2 | -1.89 Million HKD | 0.0% |
2011 Q1 | -1.89 Million HKD | 0.0% |
2011 FY | 900.54 Million HKD | 35.09% |
2011 Q4 | 165.73 Million HKD | 8844.85% |
2010 FY | 666.63 Million HKD | 15.22% |
2010 Q4 | -1.89 Million HKD | 24.69% |
2010 Q1 | -2.51 Million HKD | 0.0% |
2010 Q3 | -2.51 Million HKD | 0.0% |
2010 Q2 | -2.51 Million HKD | 0.0% |
2009 Q4 | -2.51 Million HKD | -101.74% |
2009 Q2 | 144.64 Million HKD | 0.0% |
2009 Q1 | 144.64 Million HKD | 0.0% |
2009 FY | 578.58 Million HKD | -5.29% |
2009 Q3 | 144.64 Million HKD | 0.0% |
2008 Q4 | 144.64 Million HKD | -5.29% |
2008 FY | 610.9 Million HKD | 33.55% |
2008 Q3 | 152.72 Million HKD | 0.0% |
2008 Q2 | 152.72 Million HKD | 0.0% |
2008 Q1 | 152.72 Million HKD | 0.0% |
2007 Q4 | 152.72 Million HKD | 33.55% |
2007 FY | 457.42 Million HKD | 31.91% |
2007 Q2 | 114.35 Million HKD | 0.0% |
2007 Q1 | 114.35 Million HKD | 0.0% |
2007 Q3 | 114.35 Million HKD | 0.0% |
2006 Q1 | 86.69 Million HKD | 0.0% |
2006 Q4 | 114.35 Million HKD | 31.91% |
2006 FY | 346.78 Million HKD | 15.99% |
2006 Q3 | 86.69 Million HKD | 0.0% |
2006 Q2 | 86.69 Million HKD | 0.0% |
2005 Q3 | 74.74 Million HKD | 0.0% |
2005 Q1 | 74.74 Million HKD | 0.0% |
2005 FY | 298.96 Million HKD | 0.39% |
2005 Q2 | 74.74 Million HKD | 0.0% |
2005 Q4 | 86.69 Million HKD | 15.99% |
2004 FY | 297.8 Million HKD | 0.0% |
2004 Q1 | 74.45 Million HKD | 0.0% |
2004 Q2 | 74.45 Million HKD | 0.0% |
2004 Q3 | 74.45 Million HKD | 0.0% |
2004 Q4 | 74.74 Million HKD | 0.39% |
2003 Q4 | 74.45 Million HKD | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Pak Fah Yeow International Limited | 24.42 Million HKD | -8009.802% |
Grand Pharmaceutical Group Limited | 3.86 Billion HKD | 48.694% |
Extrawell Pharmaceutical Holdings Limited | 35.52 Million HKD | -5475.303% |
Wai Yuen Tong Medicine Holdings Limited | 353.93 Million HKD | -459.636% |
Qianhai Health Holdings Limited | 17.1 Million HKD | -11481.909% |
Lee's Pharmaceutical Holdings Limited | 590.99 Million HKD | -235.155% |
Essex Bio-Technology Limited | 1.22 Billion HKD | -61.171% |
Tongfang Kontafarma Holdings Limited | 503.46 Million HKD | -293.423% |
PuraPharm Corporation Limited | 216.62 Million HKD | -814.346% |
JBM (Healthcare) Limited | 163.87 Million HKD | -1108.681% |
Jacobson Pharma Corporation Limited | 287.34 Million HKD | -589.314% |
China Resources Pharmaceutical Group Limited | 29.35 Billion HKD | 93.252% |